Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors.
Galvano A, Gristina V, Scaturro D, Bazan Russo TD, Tomasello S, Vitagliani F, Carità F, La Mantia M, Fulfaro F, Bazan V, Mauro GL, Russo A. Galvano A, et al. Among authors: scaturro d. Front Endocrinol (Lausanne). 2023 Nov 21;14:1297950. doi: 10.3389/fendo.2023.1297950. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38075057 Free PMC article.
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials.
Galvano A, Scaturro D, Badalamenti G, Incorvaia L, Rizzo S, Castellana L, Cusenza S, Cutaia S, Santini D, Guadagni F, Roselli M, Gori S, Latteri MA, Bazan V, Giulia LM, Russo A. Galvano A, et al. Among authors: scaturro d. J Bone Oncol. 2019 Jul 16;18:100252. doi: 10.1016/j.jbo.2019.100252. eCollection 2019 Oct. J Bone Oncol. 2019. PMID: 31440444 Free PMC article. Review.
Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials (Galvano et al., J Bone Oncol 2019; 18:100252).
Galvano A, Scaturro D, Bazan V, Letizia Mauro G, Russo A. Galvano A, et al. Among authors: scaturro d. J Bone Oncol. 2020 Apr 28;22:100295. doi: 10.1016/j.jbo.2020.100295. eCollection 2020 Jun. J Bone Oncol. 2020. PMID: 32742917 Free PMC article. No abstract available.
Bone damage after chemotherapy for lymphoma: a real-world experience.
Mancuso S, Scaturro D, Santoro M, Di Gaetano G, Vitagliani F, Falco V, Siragusa S, Gonnelli S, Mauro GL. Mancuso S, et al. Among authors: scaturro d. BMC Musculoskelet Disord. 2021 Dec 7;22(1):1024. doi: 10.1186/s12891-021-04904-3. BMC Musculoskelet Disord. 2021. PMID: 34876084 Free PMC article.
39 results